Pheochromocytomas and anesthesia

International Anesthesiology Clinics

Volumn 35, Issue 4, 1997, Pages 99-127

  O'Riordan, Jane A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHESIA; CARDIOMYOPATHY; CATECHOLAMINE RELEASE; DIAGNOSTIC APPROACH ROUTE; EPIDURAL ANESTHESIA; GLUCOSE INTOLERANCE; HEART ARRHYTHMIA; HYPERTENSION; LAPAROSCOPIC SURGERY; PATHOPHYSIOLOGY; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; REVIEW; SPINAL ANESTHESIA; TUMOR LOCALIZATION;

EID: 0031435999     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004311-199703540-00008     Document Type: Review

References (139)

1. Manger WM, Gifford RW Jr, Hoffman BB. Pheochromocytoma: a clinical and experimental overview. Curr Probl Cancer 1985;9:1-89
2. Stehling LC, Roizen MF. Pre-existing endocrine disorders. In: Nunn JF, Utting JE, Brown BR Jr, ed. General anaesthesia. 5th ed. London: Butterworths, 1989:392-401
3. Pullerits J, Ein S, Balfe JW. Anaesthesia for phaeochromocytoma. Can J Anaesth 1988; 35:526-534
4. Bravo EL, Gifford RW. Current concepts. Pheochromocytoma: diagnosis, localization and management. N Engl J Med 1984;311:1298-1303
5. Bouloux PMG, Grossman A, Besser GM. Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas. Clin Endocrinology 1986;24:319-325
6. Jones DJ, Burning P. Phaeochromocytoma presenting as an acute abdomen: report of two cases. Br Med J Clin Res Ed 1985;291:1267-1268
7. Sue Ling HM, Foster ME, Wheeler MH, McMahon MJ. Spontaneous rupture of phaeochromocytoma mimicking leaking aortic aneurysm. J R Soc Med 1989;82:53-54
8. Blom HJ, Karsdorp V, Birnie R, Davies G. Phaeochromocytoma as a cause of pulmonary oedema. Anaesthesia 1987;42:646-650
9. Ganguly A, Grim CE, Weinberger MH, Henry DP. Rapid cyclic fluctuations of blood pressure associated with an adrenal pheochromocytoma. Hypertension 1984;6: 281-284
10. Medvei VC, Cattell WR. Mental symptoms presenting in phaeochromocytoma: a case report and review. J R Soc Med 1988;81:550-551
11. Darby S, Prys Roberts C. Unusual presentation of phaeochromocytoma. Management of anaesthesia and cardiovascular monitoring. Anaesthesia 1976;31:913-916
12. Gan TJ, Miller RF, Webb AR, Russell RCG. Phaeochromocytoma presenting as acute hyperamylasaemia and multiple organ failure. Can J Anaesth 1994;41:244-247
13. Allen GC, Rosenberg H. Phaeochromocytoma presenting as acute malignant hyperthermia - a diagnostic challenge. Can J Anaesth 1990;37:593-595
14. Sutton MG, Sheps SG, Lie JT. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Glin Proc 1981;56:354-360
15. Page LB, Raker JW, Berberich FR. Pheochromocytoma with predominant epinephrine secretion. Am J Med 1969;47:648-652
16. Bravo EL, Tarazi RC, Gifford RW, Stewart BH. Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications. N Engl J Med 1979;301:682-686
17. Stenstrom G, Sjogren B, Waldenstrom J. Excretion of adrenaline, noradrenaline, vanilmandelic acid and metanephrines in 64 patients with pheochromocytoma. Results of repeated analyses in patients with sustained and paroxysmal hypertension. Acta Med Scand 1983;214:145-152
18. Bouloux PM. Disorders of the sympatho-adrenomedullary system. In: Bouloux PMG, Rees LH, eds. Diagnostic tests in endocrinology. London: Chapman Hall Ltd, 1994: 261-273
19. Brown MJ. Simultaneous assay of noradrenaline and its deaminated metabolite, dihydroxyphenylglycol, in plasma: a simplified approach to the exclusion of phaeochromocytoma in patients with borderline elevation of plasma noradrenaline concentration. Eur J Clin Invest 1984;14:67-72
20. Bravo EL, Tarazi RC, Fouad FM, et al. Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma. N Engl J Med 1981;305:623-626
21. Brown MJ, Allison DJ, Jenner DA, et al. Increased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma-adrenaline estimations and a pentolinium-suppression test. Lancet 1981;1:174-177
22. Jessop DS, Cunnah D, Millar JGB, et al. A phaeochromocytoma presenting with Cushing's syndrome associated with increased concentrations of circulating corticotrophin-releasing factor. J Endocrinology 1987;113:133-138
23. Adrian TE, Allen JM, Terenghi G, et al. Neuropeptide Y in phaeochromocytomas and ganglioneuroblastomas. Lancet 1983;2:540-542
24. Howlett TA, Besser GM, Rees LH. Characterization of immunoreactive dynorphin in human phaeochromocytomas. J Endocrinology 1988;117:123-132
25. Yanase T, Nawata H, Kato K, Ibayashi H. Preproenkephalin B-derived opioid peptides in human phaeochromocytomas. Acta Endocrinol Copenh 1987;114:446-451
26. Morice AH, Price JS, Ashby MJ, Brown MJ. Phaeochromocytoma with associated somatostatin production. BMJ 1989;298:1358-1359
27. Stewart AF, Hoecker JL, Mallette LE, et al. Hypercalcemia in pheochromocytoma. Evidence for a novel mechanism. Ann Intern Med 1985;102:776-779
28. Stewart BH, Bravo EL, Haaga J, et al. Localization of pheochromocytoma by computed tomography. N Engl J Med 1978;299:460-461
29. Fink IJ, Reinig JW, Dwyer AJ, et al. MR imaging of pheochromocytomas. J Comput Assist Tomogr 1985;9:454-458
30. Sisson JC, Frager MS, Valk TW, et al. Scintigraphic localization of pheochromocytoma. N Engl J Med 1981;305:12-17
31. Ackery DM, Tippett PA, Condon BR, et al. New approach to the localisation of phaeochromocytoma: imaging with iodine-131-meta-iodobenzylguanidine. Br Med J Clin Res Ed 1984;288:1587-1591
32. Francis IR, Glazer GM, Shapiro B, et al. Complementary roles of CT and 131I-MIBG scintigraphy in diagnosing pheochromocytoma. Am J Roentgenol 1983;141:719-725
33. Jones DH, Allison DJ, Hamilton CA, Reid JL. Selective venous sampling in the diagnosis and localization of phaeochromocytoma. Clin Endocrinology Oxf 1979;10:179-186
34. Allison DJ, Brown MJ, Jones DH, Timmis JB. Role of venous sampling in locating a phaeochromocytoma. Br Med J Clin Res Ed 1983;286:1122-1124
35. Roizen MF, Hunt TK, Beaupre PN, et al. The effect of alpha-adrenergic blockade on cardiac performance and tissue oxygen delivery during excision of pheochromocytoma. Surgery 1983;94:941-945
36. Desmonts JM, le Houelleur J, Remond P, Duvaldestin P. Anaesthetic management of patients with phaeochromocytoma. A review of 102 cases. Br J Anaesth 1977;49: 991-998
37. Schenker JG, Chowers I. Pheochromocytoma and pregnancy. Review of 89 cases. Obstet Gynecol Surv 1971;26:739-747
38. Stenstrom G, Haljamae H, Tisell LE. Influence of pre-operative treatment with phenoxybenzamine on the incidence of adverse cardiovascular reactions during anaesthesia and surgery for phaeochromocytoma. Acta Anaesthesiol Scand 1985;29:797-803
39. Pinaud M, Desjars P, Tasseau F, Cozian A. Preoperative acute volume loading in patients with pheochromocytoma. Crit Care Med 1985;13:460-463
40. Wallace JM, Gill DP. Prazosin in the diagnosis and treatment of pheochromocytoma. JAMA 1978;240:2752-2753
41. Cubeddu LX, Zarate NA, Rosales CB, Zschaeck DW. Prazosin and propranolol in preoperative management of pheochromocytoma. Clin Pharmacol Ther 1982;32: 156-160
42. Havlik RJ, Cahow CE, Kinder BK. Advances in the diagnosis and treatment of pheochromocytoma. Arch Surg 1988;123:626-630
43. Nicholson JP, Darracott Vaughan E, Pickering TG, et al. Pheochromocytoma and prazosin. Ann Int Med 1983;99:477-479
44. Miura Y, Yoshinaga K. Doxazosin: a newly developed, selective alpha 1-inhibitor in the management of patients with pheochromocytoma. Am Heart J 1988;116:1785-1789
45. Sloand EM, Thompson BT. Propranolol-induced pulmonary edema and shock in a patient with pheochromocytoma. .Arch Intern Med 1984;144:173-174
46. Russell WJ, Kaines AH, Hooper MJ, Frewin DB. Labetalol in the preoperative management of phaeochromocytoma. Anaesth Intens Care 1982;10:160-163
47. Rosei EA, Brown JJ, Lever AF, et al. Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol. Br J Clin Pharmac 1976;3:809-815
48. Kaufman L. Use of labetalol during hypotensive anaesthesia and in the management of phaeochromocytoma. Br J Clin Pharmacol 1979;8:229S-232S
49. Roizen MF, Horigan RW, Koike M, et al. A prospective randomized trial of four anesthetic techniques for resection of pheochromocytoma. Anesthesiology 1982;57:A43
50. Mardini MK. Echocardiographic findings in pheochromocytoma (letter). Chest 1982; 81:394-395
51. Mason RA. Phaeochromocytoma. In: Mason RA, ed. Anaesthesia databook: a clinical practice compendium. Edinburgh: Churchill Livingstone, 1990:218-223
52. Engelman K, Horwitz D, Jequier E, Sjoerdsma A. Biochemical and pharmacologic effects of alpha-methyltyrosine in man. J Clin Invest 1968;47:577-594
53. Engelman K, Sjoerdsma A. Chronic medical therapy for pheochromocytoma. A report of four cases. Ann Intern Med 1964;61:229-241
54. Gilsanz FJ, Luengo C, Conejero P, et al. Cardiomyopathy and phaeochromocytoma. Anaesthesia 1983;38:888-891
55. Fripp RR, Lee JC, Downing SE. Inotropic responsiveness of the heart in catecholamine cardiomyopathy. .Am Heart J 1981;101:17-21
56. Gonzalez Campora R, Matilla A, Carapeto R, Galera H. [Myocardiopathies caused by catecholamines. II. Morphology and pathogenesis]. Rev Clin Esp 1978;150:5-8
57. Van Vliet PD, Burchell HB, Titus JL. Focal myocarditis associated with pheochromocytoma. N Engl J Med 1966;274:1102-1108
58. Solares G, Ramos F, Martin-Duran R, et al. Amiodarone, phaeochromocytoma and cardiomyopathy. .Anaesthesia 1986;41:186-190
59. Schaffer MS, Zuberbuhler P, Wilson G, et al. Catecholamine cardiomyopathy: an unusual presentation of pheochromocytoma in children. J Pediatr 1981;99:276-279
60. Meeke RI, O'Keeffe JD, Gaffney JD. Phaeochromocytoma removal and postoperative hypoglycaemia. Anaesthesia 1985;40:1093-1096
61. Levin H, Heifetz M. Phaeochromocytoma and severe protracted postoperative hypoglycaemia. Can J Anaesth 1990;37:477-478
62. Porte D. A receptor mechanism for the inhibition of insulin release by epinephrine in man. J Clin Invest 1967;46:86
63. Mihm FG. Pulmonary artery pressure monitoring in patients with pheochromocy toma. Anesth Analg 1983;62:1129-1133
64. Varner JJ, Brunjes S. Phaeochromocytoma. Am J Cardiol 1962;9:120-125
65. Ryan T, Timoney A, Cunningham AJ. Use of transoesophageal echocardiography to manage beta-adrenoceptor block and assess left ventricular function in a patient with phaeochromocytoma. Br J Anaesth 1993;70:101-103
66. Hamaji M, Oka N, Tashiro C, et al. Anaesthetic management with morphine in phaeochromocytoma. Can Anaesth Soc J 1984;31:681-686
67. Hull CJ. Phaeochromocytoma. Diagnosis, preoperative preparation and anaesthetic management. Br J Anaesth 1986;58:1453-1468
68. Stirt JA, Brown RE Jr, Ross WT Jr, Althaus JS. Atracurium in a patient with pheochromocytoma. Anesth Analg 1985;64:547-550
69. Gencarelli PJ, Roizen MF, Miller RD, et al. ORG NC45 (Norcuron) and pheochromocytoma: a report of three cases. Anesthesiology 1981;55:690-693
70. Darowski MJ, Coutinho WB, Power SJ, Jones RM. Vecuronium and phaeochromocytoma. A report of two cases using different modes of administration. Anaesthesia 1986; 41:1225-1229
71. Jones RM, Hill AB. Severe hypertension associated with pancuronium in a patient with a phaeochromocytoma. Can Anaesth Soc J 1981;28:394-396
72. Bittar DA. Innovar-induced hypertensive crises in patients with pheochromocytoma. Anesthesiology 1979;50:366-369
73. Sumikawa K, Amakata Y. The pressor effect of droperidol on a patient with pheochromocytoma. Anesthesiology 1977;46:359-361
74. Sumikawa K, Hirano H, Amakata Y, et al. Mechanism of the effect of droperidol to induce catecholamine efflux from the adrenal medulla. Anesthesiology 1985;62:17-22
75. Clarke AD, Tobias MA, Challen PD. The use of neuroleptanalgesia during surgery for phaeochromocytoma. Reports of two cases. Br J Anaesth 1972;44:1093-1096
76. Kopriva CJ, Eltringham R. The use of enflurane during resection of a pheochromocytoma. Anesthesiology 1974;41:399-400
77. Ortiz FT, Diaz PM. Use of enflurane for pheochromocytoma removal. Anesthesiology 1975;42:495-497
78. Janeczko GF, Ivankovich AD, Glisson SN, et al. Enflurane anesthesia for surgical removal of pheochromocytoma. Anesth Analg 1977;56:62-67
79. Conner JT, Miller JD, Katz RL. Isoflurane anesthesia for pheochromocytoma: a case report. Anesth Analg 1975;54:419-421
80. Fay ML, Holzman RS. Isoflurane for resection of pheochromocytomas (letter). Anesth Analg 1983;62:955
81. Suzukawa M, Michaels IA, Ruzbarsky J, et al. Use of isoflurane during resection of pheochromocytoma. Anesth Analg 1983;62:100-103
82. Ueda N, Kitamura Y, Hayashi Y, et al. Anaesthetic management of phaeochromocytoma associated with tricuspid atresia. Can J Anaesth 1991;38:780-784
83. Doi M, Ikeda K. Sevoflurane anesthesia with adenosine triphosphate for resection of pheochromocytoma. Anesthesiology 1989;70:360-363
84. Lippmann M, Ford M, Lee C, et al. Use of desflurane during resection of phaeochromocytoma. Br J Anaesth 1994;72:707-709
85. Shapiro JD, El-Ganzouri A, White PF, Ivankovich AD. Midazolam-sufentanil anaesthesia for phaeochromocytoma resection. Can J Anaesth 1988;35:190-194
86. Bromage PR, Millar RA. Epidural blockade and circulating catecholamine levels in a child with pheochromocytoma. Can Anaesth Soc J 1958;5:282-287
87. Cousins MJ, Rubin RB. The intraoperative management of phaeochromocytoma with total epidural sympathetic blockade. Br J Anaesth 1974;46:78-81
88. Liem TH, Moll JE, Booij LH. Thoracic epidural analgesia in a patient with bilateral phaeochromocytoma undergoing coronary artery bypass grafting. Anaesthesia 1991; 46:654-658
89. Csanky-Treels JC, Lawick van Pabst WT, Brands JW, Stamenkovic L. Effects of sodium nitroprusside during the excision of phaeochromocytoma. Anaesthesia 1976;31:60-62
90. Daggett P, Verner I, Carruthers M. Intraoperative management of phaeochromocytoma with sodium nitroprusside. Br Med J 1978;2:311-313
91. Desmonts JM, Marty J. Anaesthetic management of patients with phaeochromocytoma. Br J Anaesth 1984;56:781-789
92. McDonald WN, Doll WA, Schmidt N, Reynolds C. Intravenous nitroglycerin control of blood pressure during resection of phaeochromocytoma. Can Anaesth Soc J 1982; 29:108-111
93. Bailey RR. Labetalol in the treatment of a patient with phaeochromocytoma: a case report. Br J Clin Pharmacol 1979;8:141S-142S
94. James MFM. Use of magnesium sulphate in the anaesthetic management of phaeochromocytoma: a review of 17 anaesthetics. Br J Anaesth 1989;62:616-623
95. Nicholas E, Deutschman CS, Allo M, Rock P. Use of esmolol in the intraoperative management of pheochromocytoma. Anesth Analg 1988;67:1114-1117
96. Ducey JP, Knape KG. Maternal esmolol administration resulting in fetal distress and cesarean section in a term pregnancy. Anesthesiology 1992;77:829-832
97. Tokioka H, Takahashi T, Kosogabe Y, et al. Use of diltiazem to control circulatory fluctuations during resection of a phaeochromocytoma. Br J Anaesth 1988;60:582-587
98. Munro J, Hurlbert BJ, Hill GE. Calcium channel blockade and uncontrolled blood pressure during phaeochromocytoma surgery. Can J Anaesth 1995;42:228-230
99. Arai T, Hatano Y, Ishida H, Mori K. Use of nicardipine in the anesthetic management of pheochromocytoma. Anesth Analg 1986;65:706-708
100. Proye C, Thevenin D, Cecat P, et al. Exclusive use of calcium channel blockers in preoperative and intraoperative control of pheochromocytomas: hemodynamics and free catecholamine assays in ten consecutive patients. Surgery 1989;106:1149-1154
101. Serfas D, Shoback DM, Lorell BH. Phaeochromocytoma and hypertrophic cardiomyopathy: apparent suppression of symptoms and noradrenaline secretion by calcium-channel blockade. Lancet 1983;2:711-713
102. Zakowski M, Kaufman B, Berguson P, et al. Esmolol use during resection of pheochromocytoma: report of three cases. Anesthesiology 1989;70:875-877
103. Davies AE, Navaratnarajah M. Vaginal delivery in a patient with a phaeochromocytoma. A case report. Br J Anaesth 1984;56:913-916
104. Ross EJ, Prichard BN, Kaufman L, et al. Preoperative and operative management of patients with phaeochromocytoma. Br Med J 1967;1:191-198
105. Smith AM. Phaeochromocytoma and pregnancy. J Obstet Gynaecol Br Commonw 1973;80:848-851
106. Burgess GE. Alpha blockade and surgical intervention of pheochromocytoma in pregnancy. Obstet Gynecol 1979;53:266-270
107. Lamming GD, Symonds EB. Use of labetalol and methyldopa in pregnancy-induced hvpertension. Br J Clin Pharmacol 1979;8:217S-222S
108. Michael CA. Use of labetalol in the treatment of severe hypertension during pregnancy. Br J Clin Pharmacol 1979;8:211S-215S
109. Fudge TL, McKinnon WM, Geary WL. Current surgical management of pheochromocytoma during pregnancy. Arch Surg 1980;115:1224-1225
110. Galletly DC, Yee P, Maling TJ. Anaesthetic management of combined caesarean section and phaeochromocytoma removal. Anaesth Intens Care 1983;11:249-253
111. Stonham J, Wakefield C. Phaeochromocytoma in pregnancy. Caesarean section under epidural analgesia. Anaesthesia 1983;38:654-658
112. Pattison J, Harrop Griffiths AW, Whitlock JE, Roberts JC. Caesarean section in a patient with haemoglobin SC disease and a pheochromocytoma. Anaesthesia 1990;45:958-959
113. Lieb SM, Zugaib M, Nuwayhid B, et al. Nitroprusside-induced hemodynamic alterations in normotensive and hypertensive pregnant sheep. Am J Obstet Gynerol 1981;139: 925-931
114. Naulty J, Cefalo RC, Lewis PE. Fetal toxicity of nitroprusside in the pregnant ewe. Am J Obstet Gynecol 1981;139:708-711
115. Joffe D, Robbins R, Benjamin A. Caesarean section and phaeochromocytoma resection in a patient with Von Hippel Lindau disease. Can J Anaesth 1993;40:870-874
116. James FM III. Pregnancy induced hypertension. In James FM III, Wheeler AS, Dewan DM, eds. Obstetric anesthesia: the complicated patient. 2nd ed. Philadelphia: F.A. Davis Co, 1988:417-418
117. James MF, Huddle KR, Owen AD, van der Veen BW. Use of magnesium sulphate in the anaesthetic management of phaeochromocytoma in pregnancy. Can J Anaesth 1988;35:178-182
118. Averbuch SD, Steakley GS, Young RC, et al. Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Ann Intern Med 1988;109:267-273
119. Kaufman BH, Telander RL, van Heerden JA, et al. Pheochromocytoma in the pediatric age group: current status. J Pediatr Surg 1983;18:879-884
120. Stringel G, Ein SH, Creighton R, et al. Pheochromocytoma in children - an update. J Pediatr Surg 1980;15:496-500
121. Zintel HA, Eagle JF, Skok P, Arnaud S. Pheochromocytoma in children. Surgery 1960; 47:328-339
122. Gagner M, Lacroix A, Bolte E. Laparoscopic adrenalectomy in Cushing's syndrome and pheochromocytoma (letter). N Engl J Med 1992;327:1033
123. Meurisse M, Joris J, Hamoir E, et al. Laparoscopic removal of pheochromocytoma, Why? When? and Who? (Reflextion on one case report). Surg Endoscopy 1995;9: 431-436
124. Kashtan J, Green JF, Parsons EQ, Holcroft JW. Hemodynamic effect of increased abdominal pressure. J Surg Res 1981;30:249-255
125. Joris JL, Noirot DP, Legrand MJ, et al. Hemodynamic changes during laparoscopic cholecystectomy. Anesth Analg 1993;76:1067-1071
126. Lenz RJ, Thomas TA, Wilkins DG. Cardiovascular changes during laparoscopy. Studies of stroke volume and cardiac output using impedance cardiography. Anaesthesia 1976; 31:4-12
127. O'Leary E, Hubbard K, Tormey W, Cunningham AJ. Laparoscopic cholecystectomy: haemodynamic and neuroendocrine responses after pneumoperitoneum and changes in position. Br J Anaesth 1996;76:640-644
128. Mann C, Millat B, Boccara G, Atger J, et al. Tolerance of laparoscopy for resection of phaeochromocytoma. Br J Anaesth 1996;77:795-797
129. Suzuki K, Kageyama S, Ueda D, et al. Laparoscopic adrenalectomy: clinical experience with 12 cases. J Urol 1993;150:1099-1102
130. Guazzoni G, Montorsi F, Bocciardi A, et al. Transperitoneal laparoscopic versus open adrenalectomy for benign hyperfunctioning adrenal tumors: a comparative study. J Urol 1995;153:1597-1600
131. 2 insufflation for posterior retroperitoneoscopic adrenalectomy. Anesth Analg 1996;82:827-831
132. Stenstrom G, Ernest I, Tisell LE. Long-term results in 64 patients operated upon for pheochromocytoma. Acta Med Scand 1988;223:345-352
133. James MFM. Magnesium sulfate in pheochromocytoma. Anesthesiology 1985;62: 188-189
134. James MF, Cork RC, White JF, Dennett JE. Cardiovascular effects of magnesium sulphate in the baboon. Magnesium 1987;6:314-324
135. Pritchard JA, Pritchard SA. Standardized treatment of 154 consecutive cases of eclampsia. Am J Obstet Gynecol 1975;123:543-552
136. Pritchard JA, Cunningham FG, Pritchard SA. The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases. Am J Obstet Gynecol 1984; 148:951-963
137. James MFM. Clinical use of magnesium infusions in anesthesia. Anesth Analg 1992; 74:129-136
138. Drolet P, Girard M. The use of magnesium sulfate during surgery of pheochromocytoma: 2 cases. Can J Anaesth 1993;40:521-525
139. Pivalizza EG. Magnesium sulfate and epidural anesthesia in pheochromocytoma and severe coronary artery disease. Anesth Analg 1995;81:414-416